The administration of therapeutic antibodies via injection is becoming an increasingly important healthcare treatment method for a growing number diseases and indications having broad implications for patient health and well-being. The inherent instability of protein drugs has led to a number of challenges as the developers of injectable antibodies attempt to deal with packaging, handling, reconstitution and drug administration issues. These challenges are being compounded by the trend to patient self-medication, as population demographics and efforts by managed care providers to control healthcare costs drive the growth in drug self-administration, particularly for chronic conditions. This trend is introducing a new class of na

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Injectable Antibodies: Products, Markets, Players and Forecasts
Published on May 2012
Report Summary
The administration of therapeutic antibodies via injection is becoming an increasingly important healthcare treatment method for a
growing number diseases and indications having broad implications for patient health and well-being. The inherent instability of
protein drugs has led to a number of challenges as the developers of injectable antibodies attempt to deal with packaging, handling,
reconstitution and drug administration issues. These challenges are being compounded by the trend to patient self-medication, as
population demographics and efforts by managed care providers to control healthcare costs drive the growth in drug
self-administration, particularly for chronic conditions. This trend is introducing a new class of naïve users to parenteral drug delivery.
This report analyzes twenty-six injectable/Infusible therapeutic antibody drugs and examines key packaging, dosing, regulatory,
economic and competitive factors that represent opportunities, risk factors and potential barriers to commercial success.
Highlights
· Provides detailed analysis of injectable antibody market segments, market dynamics and market demographics
· Analyzes products, therapeutic demand drivers and evaluates commercial drug products in more than two dozen injectable
antibodies
· Analyzes technologies and market development issues for injectable antibodies
· Provides market data and forecasts to 2016
· Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations
Table of Content
Summary of Contents
Executive Summary
Antibody Therapeutics Market Dynamics
The Antibody Therapeutics Marketspace
Clinical Trials and Drug Approvals
The Competitive Landscape
Demographics, Managed Care and Growth
Risks and Opportunities
Formulating Antibody Drugs
Formulation Strategies
Antibody Formulation Technologies
Injectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Antibody Packaging & Delivery
Antibody Drug Distribution Strategies
Injectable Antibodies ' Indications and Therapeutic Markets
Asthma
Infectious Disease
Oncology
Autoimmunity
Osteoporosis
Macular Degeneration
Injectable Antibody Drug Product Assessments and Forecasts
Adalimumab (Humira)
Alefacept (Amevive)
Alemtuzumab (Campath)
Belimumab (Benlysta)
Bevacizumab (Avastin)
Brentuximab vedotin (Adcetris)
Canakinumab (Ilaris)
Certolizumab (Cimzia)
Cetuximab (Erbitux)
Denosumab (Prolia)
Eculizumab (Soliris)
Gemtuzumab (Mylotarg)
Golimumab (Simponi)
Ibritumomab (Zevalin)
Infliximab (Remicade)
Natalizumab (Tysabri)
Ofatumumab (Arzerra)
Palivizumab (Synagis)
Panitumumab (Vectibix)
Omalizumab (Zolair)
Ranibizumab (Lucentis)
Rituximab (Rituxin)
Tocilizumab (Actemra)
Tositumomab (Bexxar)
Trastuzumab (Herceptin)
Ustekinumab (Stelara)
Market Factors
Regulatory Issues
Patient Compliance
Healthcare Economics
Company Profiles
Injectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Injectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Injectable Antibodies: Products, Markets, Players and Forecasts
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 3 850.00 Quantity: _____
Site License--USD 5 500.00 Quantity: _____
Corporate License--USD 8 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Injectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Injectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 5/5